Evidence map›Paper›PMID 25319519›Full record

ArticlePflugers Archiv : European journal of physiology2015

Checkpoint kinase Chk2 controls renal Cyp27b1 expression, calcitriol formation, and calcium-phosphate metabolism.

Hajar Fahkri, Bingbing Zhang, Abul Fajol, Nati Hernando, Bernat Elvira, Julia G Mannheim, Bernd J Pichler, Christoph Daniel, Kerstin Amann, Atsushi Hirao and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Inhibition of Estrogen Sulfotransferase (Journal of the American Society of Nephrology : JASN · 2020
    Article
  2. Intestinal CaWorld journal of gastroenterology · 2020
    Review
  3. Article
  4. Article
  5. Article
  6. Molecular aspects of intestinal calcium absorption.World journal of gastroenterology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 5 countries.

Hajar FahkriDepartment of Physiology, University of Tübingen, Gmelinstr. 5, 72076, Tübingen, Germany.
Bingbing Zhang
Abul Fajol
Nati Hernando
Bernat Elvira
Julia G Mannheim
Bernd J Pichler
Christoph Daniel
Kerstin Amann
Atsushi Hirao
Jillian Haight
Tak W Mak
Florian Lang
Michael Föller
University of Tübingen · DEOntario Institute for Cancer Research · CAUniversitätsklinikum Erlangen · DEKanazawa University · JPSiemens (Germany) · DEUniversity Health Network · CAUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Checkpoint kinase 2 (Chk2) is the main effector kinase of ataxia telangiectasia mutated (ATM) and responsible for cell cycle regulation. ATM signaling has been shown to upregulate interferon-regulating factor-1 (IRF-1), a transcription factor also expressed in the kidney. Calcitriol (1,25 (OH)2D3), a major regulator of mineral metabolism, is generated by 25-hydroxyvitamin D 1α-hydroxylase in the kidney. Since 25-hydroxyvitamin D 1α-hydroxylase expression is enhanced by IRF-1, the present study explored the role of Chk2 for calcitriol formation and mineral metabolism. Chk2-deficient mice (chk2 (-/-)) were compared to wild-type mice (chk2 (+/+)). Transcript levels of renal 25-hydroxyvitamin D 1α-hydroxylase, Chk2, and IRF-1 were determined by RT-PCR; Klotho expression by Western blotting; bone density by μCT analysis; serum or plasma 1,25 (OH)2D3, PTH, and C-terminal FGF23 concentrations by immunoassays; and serum, fecal, and urinary calcium and phosphate concentrations by photometry. The renal expression of IRF-1 and 25-hydroxyvitamin D 1α-hydroxylase as well as serum 1,25 (OH)2D3 and FGF23 levels were significantly lower in chk2 (-/-) mice compared to chk2 (+/+) mice. Plasma PTH was not different between the genotypes. Renal calcium and phosphate excretion were significantly higher in chk2 (-/-) mice than in chk2 (+/+) mice despite hypophosphatemia and normocalcemia. Bone density was not different between the genotypes. We conclude that Chk2 regulates renal 25-hydroxyvitamin D 1α-hydroxylase expression thereby impacting on calcium and phosphate metabolism.

Indexed as

25-Hydroxyvitamin D3 1-alpha-HydroxylaseAnimalsBlotting, WesternBone DensityCalcitriolCalciumCheckpoint Kinase 2Enzyme-Linked Immunosorbent AssayFibroblast Growth Factor-23Gene Expression RegulationGlucuronidaseHEK293 CellsHumansKidneyKlotho ProteinsMice25-Hydroxyvitamin D3 1-alpha-HydroxylaseCalcitriolCalciumCheckpoint Kinase 2Chek2 protein, mouseFGF23 protein, humanFgf23 protein, mouseFibroblast Growth Factor-23GlucuronidaseKlotho ProteinsPhosphates

Identifiers

PMID25319519
OpenAlexW2090326855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.